CDXS
Codexis IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$227.24M
P/E Ratio
—
EPS
$-0.35
Beta
2.53
52W High
$3.87
52W Low
$0.96
50-Day MA
$2.08
200-Day MA
$2.05
Dividend Yield
—
Profit Margin
-41.00%
Forward P/E
149.25
PEG Ratio
13.53
About Codexis Inc
Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $78.09M |
| Gross Profit (TTM) | $18.61M |
| EBITDA | $-20.55M |
| Operating Margin | -52.70% |
| Return on Equity | -68.90% |
| Return on Assets | -12.50% |
| Revenue/Share (TTM) | $0.88 |
| Book Value | $0.56 |
| Price-to-Book | 6.01 |
| Price-to-Sales (TTM) | 2.91 |
| EV/Revenue | 3.425 |
| EV/EBITDA | -10.67 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 102.10% |
| Shares Outstanding | $90.90M |
| Float | $72.98M |
| % Insiders | 7.41% |
| % Institutions | 74.87% |
Historical Volatility
HV 10-Day
96.24%
HV 20-Day
81.01%
HV 30-Day
83.32%
HV 60-Day
105.44%
HV Rank
59.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($6.58 target)
1
Strong Buy4
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/14/2026